- Join Us
- About the Event
- About CRI
- Why Immunotherapy
Thank you for visiting my fundraising page! I am very excited to be taking this ride in support of The Cancer Research Institute which is the world's leading nonprofit organization dedicated exclusively to harnessing the immune system's power to conquer all cancers.
My sister Ann, who I last rode a bike with about 25 years ago, will also ride in support of CRI. Ann has been following the research coming out of CRI for several years and is very hopeful with the advances they are making. My sister has 2 children who have battled cancer, so her interest is very personal.
Lauren, currently 14 and in her first year of high school, had her first cancer at 18 months and then 2 brain tumors in the past 5 years. Fortunately, her cancers were able to be treated surgically without radiation or chemotherapy.
Brent was diagnosed with osteosarchoma just before his 12th birthday. He was treated with chemotherapy and surgery and beat this cancer. However, chemotherapy often causes other cancers down the road, and Brent has battled leukemia and melanoma since beating osteosarchoma. He has had over 40 operations and missed more school than he has attended since his initial diagnosis. His older brother Alex donated bone marrow to him last year. He was recently discharged from a 7 week stay at the hospital, much of it in the Pediatric Intensive Care Unit.
This is why we are excited about the research of CRI. Immunotherapies are not toxic and do not cause the genetic damage that can cause other cancers and organ damage down the road.
Please help me in supporting this important research. CRI scores 94.69 out of 100 on charity navigator. They are developing some very promising therapies which may prove to cure cancers more humanely and more permanently than the therapies that are currently available.
Stephen, diagnosed with metastatic colorectal cancer at 28, enrolled in a clinical trial for a checkpoint inhibitor, a type of immunotherapy.
Read Stephen's Story
Deborah, who was treated with the immunotherapy Yervoy" in combination with radiation for stage III melanoma, participated in the 2016 Answer to Cancer cycling event to raise funds for CRI.
Read Deborah's Story
In 2012, life-long Tennessean Philip was shocked to learn that he had kidney cancer. Not satisfied with the chemotherapy options presented to him, Philip enrolled a clinical trial for the immunotherapy nivolumab (Opdivo").
Read Philip's Story